BUY IPCA Laboratories Limited — Vikas Sethi, Sethi Finmart
byVikas Sethi, Sethi FinmartHorizon: 1 year23 Oct 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·23 Oct · today
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·22 Oct · yesterday
Ipca Laboratories stock reports stronger Q1 growth as guidance rises
NewsGoogle News·7 Oct · 2w ago
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·14 Aug · 2mo ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Kunal Saraogi23 Oct 2026 · ~3 months · target ₹2,350 · Active
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · ~1 year · target ₹2,300 · SL hit
- BUY — Sudeep Shah, SBICAP Securities5 Oct 2026 · ~3 months · target ₹2,040 · SL hit
- BUY — Vikas Sethi, Sethi Finmart1 Oct 2026 · ~2 weeks · target ₹1,990 · SL hit
More from Vikas Sethi, Sethi Finmart
- BUY Bharti Airtel23 Oct 2026 · Same day · target ₹1,915 · Active
- BUY AU Small Finance Bank23 Oct 2026 · Same day · target ₹962 · SL hit
- BUY Wipro23 Oct 2026 · Same day · target ₹196 · Active
- BUY CREDITACCESS GRAMEEN23 Oct 2026 · Same day · target ₹1,120 · Expired
- BUY Infosys23 Oct 2026 · Same day · target ₹1,175 · Expired

